The Lancet, 402 (10402), 613626
However, native GLP-1 has a limited half-life (1.55 min) due to its degradation by the enzyme Dipeptidyl peptidase 4 (DPP-4), necessitating the development of GLP-1 receptor agonists (GLP-1RAs) with longer activity (Campbell and Drucker 2013)
The World Anti-Doping Agency prohibits IGF-1 and related analogs under S2, and athletes should verify current anti-doping rules before use
When a hospital admits a patient, the pharmacy team can provide invaluable insights to the nursing staff on weight loss drugs obtained from traditional as well as online platforms
As of December 2025, the FDA approved the Wegovy pill, providing a non-injectable option for those who prefer it
Fair allocation of GLP-1 and dual GLP-1-GIP receptor agonists